Edwards Lifesciences announced data demonstrating successful patient outcomes supporting its portfolio of mitral and tricuspid therapies. One-year data from the ENCIRCLE single-arm pivotal trial achieved all primary and… read more.
Amarin Corporation highlighted a new post hoc analysis of aspirin use in REDUCE-IT® reinforcing that icosapent ethyl significantly reduced cardiovascular (CV) events in high-risk patients. These findings highlight the… read more.
A new study led by researchers from Murdoch University’s School of Psychology, Personalised Medicine Centre, and Centre for Healthy Ageing, Health Futures Institute has found that Heart Rate Variability… read more.
Obese or overweight non-diabetic adults with atrial fibrillation (Afib) who take the diabetes medication metformin after a catheter ablation are more likely to remain free of AFib for… read more.
Adults treated for atrial fibrillation (AFib/AF) who consume a daily cup of coffee are 39% less likely to have an irregular heart rhythm episode compared to those who… read more.
A major international study involving 23,000 people has found concerning evidence about the impact of a range of common, everyday medications on the treatment outcomes for patients with… read more.
The rapidly expanding availability of remote telehealth cardiac health care poses a growing challenge for health care providers to learn how to use new digital tools and resources… read more.
Researchers report that people drinking three or more alcoholic drinks per day are at a significantly greater risk of intracerebral hemorrhage (a type of stroke caused by bleeding… read more.
A prospective population-based cohort study of suboptimally active adults (<8,000 steps per day) assessed whether individuals who accumulate their daily steps in shorter or longer bouts are at… read more.
The electronic health record data analysed in this study is anonymised and never leaves a secure data environment, which is only accessible by approved researchers working on approved… read more.
A new analysis of the SELECT trial – the largest and longest clinical trial to date examining the cardiovascular benefits of semaglutide (a medication used to support weight… read more.
Sudden cardiac death is responsible for an unusually high proportion of deaths in female bodybuilders worldwide, according to research published in the European Heart Journal [1] today (Tuesday). Sudden cardiac… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
